XML 19 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2015   14,653,985          
Beginning balance at Dec. 31, 2015 $ 212.2 $ 14.7 $ 99.0 $ 168.3 $ (46.7) $ (30.0) $ 6.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Comprehensive income (loss) 19.5     31.7   (12.7) 0.5
Stock-based compensation 10.6   10.6        
Restricted stock awards (in shares)   172,550          
Restricted stock awards issued 0.0 $ 0.2 (0.2)        
Restricted stock cancelled (in shares)   (4,000)          
Restricted stock cancelled 0.0            
Performance shares issued (in shares)   1,500          
Performance shares issued 0.0            
Exercise of stock options, Number of Shares (in shares)   22,000          
Exercise of stock options 0.5   0.5        
Dividends (6.2)     (6.2)      
Purchase of treasury stock (1.9)       (1.9)    
Income tax effect of share-based compensation exercises and vesting (0.6)   (0.6)        
Acquisition and adjustments 2.1           2.1
Other (0.2)   (0.5) (0.2)     0.5
Ending balance (in shares) at Dec. 31, 2016   14,846,035          
Ending balance at Dec. 31, 2016 $ 236.0 $ 14.9 108.8 193.6 (48.6) (42.7) 10.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend per common share (in dollars per share) $ 0.50            
Comprehensive income (loss) $ 54.3     28.6   24.8 0.9
Stock-based compensation 8.6   8.6        
Restricted stock awards (in shares)   266,280          
Restricted stock awards issued 0.0 $ 0.3 (0.3)        
Restricted stock cancelled (in shares)   (2,000)          
Restricted stock cancelled 0.0            
Performance shares issued (in shares)   4,694          
Performance shares issued 0.0            
Exercise of stock options, Number of Shares (in shares)   38,000          
Exercise of stock options 0.7   0.7        
Dividends (6.9)     (6.3)     (0.6)
Purchase of treasury stock (6.6)       (6.6)    
Acquisition and adjustments 1.7           1.7
Other 0.2     0.2      
Ending balance (in shares) at Dec. 31, 2017   15,153,009          
Ending balance at Dec. 31, 2017 $ 288.0 $ 15.2 117.8 216.1 (55.2) (17.9) 12.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend per common share (in dollars per share) $ 0.50            
Comprehensive income (loss) $ 32.2     53.6   (23.0) 1.6
Stock-based compensation 8.3   8.3        
Restricted stock awards (in shares)   410,100          
Restricted stock awards issued 0.0 $ 0.4 (0.4)        
Restricted stock cancelled (in shares)   (7,834)          
Restricted stock cancelled 0.0            
Dividends (6.4)     (6.4)      
Purchase of treasury stock (12.1)       (12.1)    
Ending balance (in shares) at Dec. 31, 2018   15,555,275          
Ending balance at Dec. 31, 2018 $ 312.6 $ 15.6 $ 125.7 $ 265.9 $ (67.3) $ (40.9) $ 13.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividend per common share (in dollars per share) $ 0.50